Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinal Oxygen Saturation During Hypoxia and Hyperoxia
NCT01692821Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2012
- Primary completion
- Dec 2012
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxygen, sponsored by Medical University of Vienna. Primary endpoint: Retinal oxygen saturation. Started Jun 2012; status: completed.
02
Drugs
oxygen
Beyond the preview
Go deeper on NCT01692821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01692821.